Related Experiment Video
Updated: Apr 16, 2026
14:24
Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
12.3K
The changes in cardiac physiology with aging and the implications for the treating oncologist
Dipti Gupta1, Shivani Verma2, Shawn C Pun2
1Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA.
Journal of Geriatric Oncology
|March 12, 2015
Summary
Cardiovascular aging influences cancer treatments. Understanding age-related heart changes is crucial for oncologists managing cancer patients undergoing therapy.
Area of Science:
- Cardiology
- Oncology
- Gerontology
Background:
- The interconnectedness of cancer, cardiovascular disease, and aging is established.
- Cardiovascular aging involves significant physiological and pathological alterations.
Purpose of the Study:
- To review the physiological and pathological changes in cardiovascular aging.
- To examine the interplay between cardiovascular aging and cancer therapies.
- To discuss the implications for oncologists.
Main Methods:
- Literature review of studies on cardiovascular aging and cancer therapy interactions.
- Analysis of physiological and pathological changes associated with aging hearts.
- Synthesis of current knowledge on managing cardiovascular risks in cancer patients.
Main Results:
- Cardiovascular aging presents unique challenges when patients undergo cancer treatment.
- Specific age-related cardiovascular changes can affect treatment tolerance and outcomes.
- Understanding these interactions is vital for personalized cancer care.
Conclusions:
- Oncologists must consider the cardiovascular aging status of patients when planning cancer therapies.
- Proactive management of age-related cardiovascular changes can improve patient safety and treatment efficacy.
- Further research is needed to optimize cancer treatment strategies for aging cardiovascular systems.
Related Concept Videos
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
353
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
353
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
343
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
343
01:15Drug Dosing: Geriatric Patients
374
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
374
01:19The Effect of Aging on Tissues
4.2K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
4.2K
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
356
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
356
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
817
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
817